- CONSORT Statement
- CONSORT Statement Extensions
- Evidence underpinning CONSORT
- Accrual and sample size
- Attitudes to trials
- Adverse events (Harms)
- Baseline data
- Blinding
- Compliance
- Early stopping
- Eligibility
- Follow-up
- Funding
- Harms
- Generalizability
- Intention to treat
- Interpretation
- Interventions
- Outcome reporting
- Random allocation
- Recruitment
- Statistical analysis
- Statistical methods
- Trial design issues
- Trial registration
- Uptake of CONSORT by journals
- Impact of and adherence to CONSORT
- Endorsement of CONSORT
Cluster trials
Bowater RJ, Abdelmalik SM, Lilford RJ. The methodological quality of
cluster
randomised controlled trials for managing tropical parasitic disease: a
review
of trials published from 1998 to 2007. Trans R Soc Trop Med Hyg 2009;
103(5):429-436.
PMID: 19232658 [New]
Campbell MK, Grimshaw JM. Cluster
randomised trials: time for improvement. The implications of adopting a cluster
design are still largely being ignored. BMJ 1998; 317(7167):1171-1172.
PMID: 9794847
Freemantle N, Wood J. Cluster randomised trials.
Standardised approach to analysing and reporting these trials is misguided. BMJ
1999; 318(7193):1286-1287.
PMID: 10231274
Laopaiboon M. Meta-analyses involving cluster randomization
trials: a review of published literature in health care. Stat Methods Med Res
2003; 12(6):515-530.
PMID: 14653354
Taljaard M, McGowan J, Grimshaw JM, Brehaut JC, McRae A, Eccles MP,
Donner A.
Electronic search strategies to identify reports of cluster randomized
trials in
MEDLINE: low precision will improve with adherence to reporting
standards. BMC
Med Res Methodol 2010; 10(1):15.
PMID: 20158899
[New]
Torgerson DJ. Contamination in trials: is cluster
randomisation the answer? BMJ 2001; 322(7282):355-357.
PMID: 11159665
Page last edited: 23 March 2010
